Home/Filings/4/0001127602-25-003958
4//SEC Filing

Kramer Robin 4

Accession 0001127602-25-003958

CIK 0000875045other

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 6:48 PM ET

Size

15.6 KB

Accession

0001127602-25-003958

Insider Transaction Report

Form 4
Period: 2025-02-06
Kramer Robin
Chief Accounting Officer
Transactions
  • Award

    Restricted Stock Unit

    2025-02-06+10,53510,535 total
    Exercise: $0.00Exp: 2025-02-06Common Stock (10,535 underlying)
  • Tax Payment

    Common Stock

    2025-02-07$141.35/sh232$32,7936,963.748 total
  • Exercise/Conversion

    Common Stock

    2025-02-07+7037,666.748 total
  • Exercise/Conversion

    Common Stock

    2025-02-07+7887,195.748 total
  • Tax Payment

    Common Stock

    2025-02-07$141.35/sh244$34,4897,422.748 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-07788789 total
    Exercise: $0.00Exp: 2026-02-08Common Stock (788 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-077031,407 total
    Exercise: $0.00Exp: 2027-02-07Common Stock (703 underlying)
Footnotes (3)
  • [F1]The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025.
  • [F2]The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023.
  • [F3]The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.

Issuer

BIOGEN INC.

CIK 0000875045

Entity typeother

Related Parties

1
  • filerCIK 0001609222

Filing Metadata

Form type
4
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 6:48 PM ET
Size
15.6 KB